1. Home
  2. ELVN vs DQ Comparison

ELVN vs DQ Comparison

Compare ELVN & DQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELVN
  • DQ
  • Stock Information
  • Founded
  • ELVN 2016
  • DQ 2006
  • Country
  • ELVN United States
  • DQ China
  • Employees
  • ELVN N/A
  • DQ N/A
  • Industry
  • ELVN Biotechnology: Pharmaceutical Preparations
  • DQ Semiconductors
  • Sector
  • ELVN Health Care
  • DQ Technology
  • Exchange
  • ELVN Nasdaq
  • DQ Nasdaq
  • Market Cap
  • ELVN 1.2B
  • DQ 970.3M
  • IPO Year
  • ELVN 2020
  • DQ 2010
  • Fundamental
  • Price
  • ELVN $20.73
  • DQ $18.95
  • Analyst Decision
  • ELVN Strong Buy
  • DQ Hold
  • Analyst Count
  • ELVN 5
  • DQ 5
  • Target Price
  • ELVN $41.20
  • DQ $22.26
  • AVG Volume (30 Days)
  • ELVN 747.2K
  • DQ 909.6K
  • Earning Date
  • ELVN 08-12-2025
  • DQ 08-25-2025
  • Dividend Yield
  • ELVN N/A
  • DQ N/A
  • EPS Growth
  • ELVN N/A
  • DQ N/A
  • EPS
  • ELVN N/A
  • DQ N/A
  • Revenue
  • ELVN N/A
  • DQ $737,683,000.00
  • Revenue This Year
  • ELVN N/A
  • DQ N/A
  • Revenue Next Year
  • ELVN N/A
  • DQ $93.91
  • P/E Ratio
  • ELVN N/A
  • DQ N/A
  • Revenue Growth
  • ELVN N/A
  • DQ N/A
  • 52 Week Low
  • ELVN $13.30
  • DQ $12.41
  • 52 Week High
  • ELVN $30.03
  • DQ $30.85
  • Technical
  • Relative Strength Index (RSI)
  • ELVN 52.08
  • DQ 82.04
  • Support Level
  • ELVN $19.22
  • DQ $14.87
  • Resistance Level
  • ELVN $21.90
  • DQ $15.88
  • Average True Range (ATR)
  • ELVN 1.49
  • DQ 0.74
  • MACD
  • ELVN -0.19
  • DQ 0.46
  • Stochastic Oscillator
  • ELVN 39.43
  • DQ 95.99

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

About DQ DAQO New Energy Corp.

Daqo New Energy Corp is a polysilicon manufacturer based in China. The company manufactures and sells high-purity polysilicon to manufacturers who use it to make ingots, cells, and modules for solar power solutions. The polysilicon is packaged to meet crucible stacking, pulling, and solidification needs. All of the company's revenues come from the People's Republic of China.

Share on Social Networks: